Real-time enrollment status for this systemic lupus erythematosus clinical trial
Current Status
Recruiting
Checked: September 6, 2026 at 5:41 AM UTC
| NCT Number | NCT06594068 |
| Recruiting Status | Recruiting |
| Condition | Systemic Lupus Erythematosus |
| Phase | PHASE4 |
| Target Enrollment | 16 participants |
| Active Locations | 1 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | August 18, 2026 (2 weeks ago) |
As of September 6, 2026: Clinical trial NCT06594068 is currently recruiting participants. This phase4 study for systemic lupus erythematosus is actively seeking new participants at 1 location across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06594068 is actively recruiting participants as of September 6, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06594068 was last updated 2 weeks ago (August 18, 2026). HelloStudys verifies this status automatically.